Alexion Pharmaceuticals
ALXN
#630
Rank
โ‚น3.660 T
Marketcap
โ‚น16,564
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Alexion Pharmaceuticals (ALXN)

Revenue in 2021 (TTM): โ‚น462.63 Billion

According to Alexion Pharmaceuticals's latest financial reports the company's current revenue is โ‚น568.17 Billion. In 2020 the company made a revenue of โ‚น550.83 Billion an increase over the revenue in the year 2019 that were of โ‚น452.89 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alexion Pharmaceuticals from 2001 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚น462.63 B-16.01%
2020โ‚น550.83 B21.63%
2019โ‚น452.89 B20.82%
2018โ‚น374.84 B16.36%
2017โ‚น322.15 B15.17%
2016โ‚น279.72 B18.42%
2015โ‚น236.20 B16.51%
2014โ‚น202.73 B43.99%
2013โ‚น140.80 B36.79%
2012โ‚น102.93 B44.76%
2011โ‚น71.10 B44.82%
2010โ‚น49.09 B39.85%
2009โ‚น35.10 B49.29%
2008โ‚น23.51 B259.66%
2007โ‚น6.53 B4523.88%
2006โ‚น0.14 B13.14%
2005โ‚น0.12 B-70.12%
2004โ‚น0.41 B557.49%
2003โ‚น63.62 M-85.98%
2002โ‚น0.45 B-50.6%
2001โ‚น0.91 B